Sakar Healthcare Ltd.
SAKAR Share PricePharmaceuticals & Drugs
₹385.55
-0.5 (-0.1%)
As on December 4, 2025
Exchange Scrips: BSENSESAKARISININE732S01012
Market Cap ₹ 859 Cr
P/E Ratio 48.35
Dividend Yield N/A
Performance
Market performance
Open385.9
High388.5
Volumes13,217
Prev385.55
Low381
As on2025-12-04
Historical performance
1 Year High411.8
3 Year High479
5 Year High479
1 Year Low210.1
3 Year Low185.55
5 Year Low84.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
859
Face Value (₹)
10
P/E Ratio
48.35
Dividend Yield
N/A
Investment Returns
1 Year
21.6%
3 Years
52.9%
5 Years
320.7%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 385.2 | Bullish |
| 10-DMA | 376.68 | Bullish |
| 20-DMA | 386.78 | Bearish |
| 50-DMA | 371.32 | Bullish |
| 100-DMA | 355.67 | Bullish |
| 200-DMA | 321.28 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 4 | 4 | 4 | 4 | 4 |
| Public Investors | 7561 | 8111 | 8604 | 8594 | 7863 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 48.35.
- 3Y Stock Price CAGR of the stock is 16.8.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹510 Million.
- The company generated revenue of ₹1776 Million in the previous financial year.
Sakar Healthcare Ltd.
385.55-0.5 (-0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1220481.2
No. of Shares: 3166 (Approx)
Performance:22%
P/L: ₹220481.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
